{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T03:39:40Z","timestamp":1789011580342,"version":"build-2803163510"},"reference-count":28,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2012,4]]},"DOI":"10.1097\/coc.0b013e318209aa41","type":"journal-article","created":{"date-parts":[[2011,2,18]],"date-time":"2011-02-18T04:19:25Z","timestamp":1298002765000},"page":"146-150","source":"Crossref","is-referenced-by-count":20,"title":["Herpesviridae Viral Infections After Chemotherapy Without Antiviral Prophylaxis in Patients With Malignant Lymphoma"],"prefix":"10.1097","volume":"35","author":[{"given":"Ho Sup","family":"Lee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ji Young","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seong Hoon","family":"Shin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sung Bin","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin Soo","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aeran","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Byeong Jin","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang Soo","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-10-20210128","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1159\/000149269","article-title":"Herpesviridae. Definition, provisional nomenclature, and taxonomy. The Herpesvirus Study Group, the International Committee on Taxonomy of Viruses.","volume":"16","author":"Roizman","year":"1981","journal-title":"Intervirology"},{"key":"R2-10-20210128","first-page":"425","article-title":"The family Herpesviridae: an update. The Herpesvirus Study Group of the International Committee on Taxonomy of Viruses.","volume":"123","author":"Roizman","year":"1992","journal-title":"Arch Virol"},{"key":"R3-10-20210128","doi-asserted-by":"crossref","first-page":"1800","DOI":"10.1182\/blood-2005-09-3624","article-title":"Long-term acyclovir for prevention of varicella zoster virus disease after allogeneic hematopoietic cell transplantation: a randomized double-blind placebo-controlled study.","volume":"107","author":"Boeckh","year":"2006","journal-title":"Blood"},{"key":"R4-10-20210128","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/S0308-2261(21)00449-5","article-title":"Herpes virus infections: clinical manifestations and therapeutic strategies in immunocompromised patients.","volume":"13","author":"Saral","year":"1984","journal-title":"Clin Haematol"},{"key":"R5-10-20210128","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1182\/blood.V74.4.1424.1424","article-title":"Herpes zoster infection after autologous bone marrow transplantation.","volume":"74","author":"Schuchter","year":"1989","journal-title":"Blood"},{"key":"R6-10-20210128","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1590\/S1413-86702005000400010","article-title":"A non-randomized comparative study using different doses of acyclovir to prevent herpes simplex reactivation in patients submitted to autologous stem cell transplantation.","volume":"9","author":"Atalla","year":"2005","journal-title":"Braz J Infect Dis"},{"key":"R7-10-20210128","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1038\/sj.bmt.1703817","article-title":"Clinical utility of oral valacyclovir compared with oral acyclovir for the prevention of herpes simplex virus mucositis following autologous bone marrow transplantation or stem cell rescue therapy.","volume":"31","author":"Eisen","year":"2003","journal-title":"Bone Marrow Transplant"},{"key":"R8-10-20210128","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1093\/annonc\/mdj132","article-title":"Antiviral prophylaxis in patients with haematological malignancies and solid tumours: Guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society for Hematology and Oncology (DGHO).","volume":"17","author":"Sandherr","year":"2006","journal-title":"Ann Oncol"},{"key":"R9-10-20210128","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/S1083-8791(00)70051-6","article-title":"Varicella zoster virus infections following allogeneic bone marrow transplantation: frequency, risk factors, and clinical outcome.","volume":"6","author":"Koc","year":"2000","journal-title":"Biol Blood Marrow Transplant"},{"key":"R11-10-20210128","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1053\/bbmt.2001.v7.pm11777100","article-title":"Guidelines for preventing opportunistic infections among hematopoietic stem cell transplant recipients: focus on community respiratory virus infections.","volume":"7","author":"Dykewicz","year":"2001","journal-title":"Biol Blood Marrow Transplant"},{"key":"R12-10-20210128","first-page":"125","article-title":"Guidelines for preventing opportunistic infections among hematopoietic stem cell transplant recipients.","volume":"49","author":"Dykewicz","year":"2000","journal-title":"MMWR Recomm Rep"},{"key":"R13-10-20210128","first-page":"277","article-title":"Varicella zoster infection after bone marrow transplantation: incidence, risk factors and complications.","volume":"13","author":"Han","year":"1994","journal-title":"Bone Marrow Transplant"},{"key":"R14-10-20210128","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1093\/infdis\/152.6.1172","article-title":"Infection with varicella-zoster virus after marrow transplantation.","volume":"152","author":"Locksley","year":"1985","journal-title":"J Infect Dis"},{"key":"R15-10-20210128","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1038\/bjc.1984.138","article-title":"Oral acyclovir prophylaxis against herpes simplex virus in non-Hodgkin lymphoma and acute lymphoblastic leukaemia patients receiving remission induction chemotherapy. A randomised double blind, placebo controlled trial.","volume":"50","author":"Anderson","year":"1984","journal-title":"Br J Cancer"},{"key":"R16-10-20210128","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1002\/cncr.23144","article-title":"Consolidation and maintenance immunotherapy with rituximab improve clinical outcome in patients with B-cell chronic lymphocytic leukemia.","volume":"112","author":"Del Poeta","year":"2008","journal-title":"Cancer"},{"key":"R17-10-20210128","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1007\/s10354-004-0067-y","article-title":"Opportunistic infections after treatment with monoclonal antibodies.","volume":"154","author":"Cornely","year":"2004","journal-title":"Wien Med Wochenschr"},{"key":"R18-10-20210128","doi-asserted-by":"crossref","first-page":"4416","DOI":"10.1182\/blood-2003-10-3411","article-title":"Prolonged treatment with rituximab in patients with follicular lymphoma significantly increases event-free survival and response duration compared with the standard weekly 4 schedule.","volume":"103","author":"Ghielmini","year":"2004","journal-title":"Blood"},{"key":"R19-10-20210128","first-page":"99","article-title":"Alteration in antibody-mediated immunity in patients with rituximab-combined chemotherapy and incidence of herpes zoster.","volume":"37","author":"Ito","year":"2010","journal-title":"Gan To Kagaku Ryoho"},{"key":"R20-10-20210128","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1136\/bmj.287.6389.384","article-title":"Acyclovir prophylaxis against herpes virus infections in severely immunocompromised patients: randomised double blind trial.","volume":"287","author":"Hann","year":"1983","journal-title":"Br Med J (Clin Res Ed)"},{"key":"R21-10-20210128","first-page":"99","article-title":"Prevention of herpes zoster in patients by long-term oral acyclovir after allogeneic bone marrow transplantation.","volume":"85","author":"Perren","year":"1988","journal-title":"Am J Med"},{"key":"R22-10-20210128","first-page":"495","article-title":"Long-term acyclovir prophylaxis for prevention of varicella zoster virus infection after autologous blood stem cell transplantation in patients with acute leukemia.","volume":"10","author":"Sempere","year":"1992","journal-title":"Bone Marrow Transplant"},{"key":"R23-10-20210128","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1038\/bjc.1989.88","article-title":"The prophylactic role of intravenous and long-term oral acyclovir after allogeneic bone marrow transplantation.","volume":"59","author":"Selby","year":"1989","journal-title":"Br J Cancer"},{"key":"R24-10-20210128","doi-asserted-by":"crossref","first-page":"3071","DOI":"10.1182\/blood-2007-03-077644","article-title":"One-year acyclovir prophylaxis for preventing varicella-zoster virus disease after hematopoietic cell transplantation: no evidence of rebound varicella-zoster virus disease after drug discontinuation.","volume":"110","author":"Erard","year":"2007","journal-title":"Blood"},{"key":"R25-10-20210128","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1002\/ajh.21152","article-title":"Long-term ultra-low-dose acyclovir against varicella-zoster virus reactivation after allogeneic hematopoietic stem cell transplantation.","volume":"83","author":"Asano-Mori","year":"2008","journal-title":"Am J Hematol"},{"key":"R26-10-20210128","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1038\/sj.bmt.1703214","article-title":"Long-term low-dose acyclovir against varicella-zoster virus reactivation after allogeneic hematopoietic stem cell transplantation.","volume":"28","author":"Kanda","year":"2001","journal-title":"Bone Marrow Transplant"},{"key":"R27-10-20210128","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1111\/j.1399-0012.2008.00877.x","article-title":"Clinical efficacy of prophylactic strategy of long-term low-dose acyclovir for varicella-zoster virus infection after allogeneic peripheral blood stem cell transplantation.","volume":"22","author":"Kim","year":"2008","journal-title":"Clin Transplant"},{"key":"R28-10-20210128","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1007\/BF00366060","article-title":"Oral acyclovir as prophylaxis for bacterial infections during induction therapy for acute leukaemia in adults. The Leukemia Group of Middle Sweden.","volume":"1","author":"Lonnqvist","year":"1993","journal-title":"Suppor Care Cancer"},{"key":"R29-10-20210128","doi-asserted-by":"crossref","first-page":"773","DOI":"10.7326\/0003-4819-99-6-773","article-title":"Acyclovir prophylaxis against herpes simplex virus infection in patients with leukemia. A randomized, double-blind, placebo-controlled study.","volume":"99","author":"Saral","year":"1983","journal-title":"Ann Intern Med"}],"container-title":["American Journal of Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/COC.0b013e318209aa41","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T18:52:52Z","timestamp":1786042372000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00000421-201204000-00010"}},"subtitle":["Incidence and Risk Factors"],"short-title":[],"issued":{"date-parts":[[2012,4]]},"references-count":28,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2012]]}},"URL":"https:\/\/doi.org\/10.1097\/coc.0b013e318209aa41","relation":{},"ISSN":["0277-3732"],"issn-type":[{"value":"0277-3732","type":"print"}],"subject":[],"published":{"date-parts":[[2012,4]]}}}